Structure Therapeutics Inc. earns a Strong Buy rating following robust phase 2b data for oral GLP-1R agonist Aleniglipron in obesity. Aleniglipron achieved placebo-adjusted weight loss up to -15.3% at ...

Placebo-adjusted mean weight loss of 11.3% (27.3 lbs) with 120 mg dose in the 36-week Phase 2b ACCESS study with a 10.4% adverse event-related treatment discontinuation Placebo-adjusted mean weight ...

SAN FRANCISCO, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for ...

SAN FRANCISCO, Dec. 07, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic ...

The CTSC Community Engaged Research Embedded Scholars Program is a new opportunity being offered to CTSC affiliated faculty and community partners to take a deeper dive in their research partnerships.

College students are meeting with “embedded” counselors in residence halls and academic buildings, with promising results. By Christina Caron As a child, Xiomara Garcia, 21, assumed that attending a ...

In the rapidly changing financial landscape of 2025, two interconnected trends are gaining real traction: autonomous finance and embedded AI. Each independently marks a significant shift. Together, ...

Instructure, the company behind the widely used Canvas learning management system, announced two developments last week aimed at expanding the use of artificial intelligence within its learning ...

Singapore-based Fintech firms Green Link Digital Bank (GLDB) and 129Knots have launched a global embedded finance initiative targeting liquidity gaps in the marine fuel sector, aiming to bring ...

Venture Partners at CU Boulder has helped faculty and researchers from the University of Colorado build over 220 new ventures based on technology and innovation from CU Boulder, UCCS and CU Denver.